DaviesB. M. and BeechH. R.: The effect of 1-aryl-cyclohexylamine (Sernyl) on twelve normal volunteers.J. Ment. Sci.106: 912–924, 1960.
2.
FlügelF. and ItilT.: Klinishe-elektroencephalographische Untersuchungen mit “Verwirrheit” hervorrufenden Substanzen.Psychopharmacologia3: 79–98, 1962.
3.
FreemanW. and WattsJ. W.: Retrograde degeneration of the thalamus following prefrontal lobotomy.J. Comp. Neurol.86: 65–93, 1947.
4.
GoldmanD.: Differential response to drugs useful in treatment of psychoses revealed by pentothal-activated EEG. In WortisJ., Ed.: Recent Advances in Biological Psychiatry.New York, Grune & Stratton, 2: 250–267, 1960.
5.
GreifensteinF. E., DevaultM., YoshitakeJ. and GajewskiJ. E.: A study of a 1-arylcyclohexylamine for anesthesia.Anesth. Analg.37: 283–294, 1958.
6.
HarrisM. M., HorwitzW. A. and MilchE. A.: Regarding sodium amytal as a prognostic aid in insulin and metrazol shock therapy of mental patients (dementia praecox).Amer. J. Psychiat.96: 327–333, 1939.
7.
ItilT.: Elektroencephalographische Studien bei Psychosen und psychotropen Medikamenten.Istanbul, Ahmet Sait Matbaasi, 1964.
8.
ItilT., HoldenJ. M. C., KeskinerA. and FinkM.: Increased sensitivity to centrally active drugs following lobotomy. Presented at the Society of Biological Psychiatry Meeting, Washington, D.C., June 9–12, 1966, Recent Advances Biol. Psychiat. Vol.9 (in press).
9.
LangfeldtG.: The prognosis of schizophrenia.Acta Psychiat. Neurol. Scand. Suppl.110: 1–66, 1956.
10.
LennoxM. A. and CoolidgeJ.: Electroencephalographic changes after prefrontal lobotomy and topectomy in chronic psychoses.Arch. Neurol. Psychiat.62: 150–161, 1949.
11.
LubyE. D., CohenB. D., RosenbaumG., GottliebJ. S. and KellyR.: Study of a new schizophrenomimetic drug — Sernyl.A.M.A. Arch. Neurol Psychiat.81: 363–369, 1959.
12.
MeyerJ. S., GreifensteinF. and DevaultM. A.: A new drug causing symptoms of sensory deprivation, J. Nerv. Ment. Dis.129: 54–61, 1959.
13.
RodinE. A., LubyE. D. and MeyerJ. S.: Electroencephalographic findings associated with Sernyl infusion.Electroenceph. Clin. Neurophysiol.11: 796–798, 1959.
14.
ShagassC.: A measurable neurophysiologic factor of psychiatric significance.Electroenceph. Clin. Neurophysiol.9: 101–108, 1957.